Clin2
NCT05913999Possibly a fitEnrolling by invitation

PET and heart scans during early chemotherapy

CancerChemotherapeutic ToxicityCoronary Artery DiseaseCoronary Microvascular Disease

Part of Cancer, Heart & circulation clinical trials.

This trial studies how a specialized heart imaging test (PET/MPI) changes during the start of chemotherapy for cancer patients. It may help researchers understand whether this monitoring approach detects heart strain early and keeps patients safer during treatment.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
60 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are a cancer patient receiving care through the VA system
  • You are about to start chemotherapy (not already on it)
  • You can understand the study and sign consent
  • You have not had chemotherapy before
  • You have not had heart procedures like stents or bypass surgery in the past
  • You do not have known weak heart pumping (rest ejection fraction under 50%) and you do not have a history of organ transplant

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07761728Enrolling by invitation
Comparing two heart PET scan tracers

This study compares two types of radioactive tracers used during heart PET scans to see if one is better at detecting blocked arteries. Participation involves receiving one of the tracers during your routine scan and may help improve heart disease diagnosis.

Los Angeles, California
NCT05865600Recruiting
PET/CT guided planning for treatment in chronic coronary disease

This trial uses a heart scan (PET/CT) to better estimate blood flow in people with long-term coronary artery disease. It aims to help doctors choose the best treatment strategy and decide who may need more invasive testing or procedures.

Herning, Central Jutland
NCT06373497Recruiting· Early Phase 1
Heart artery health after chest radiation using PET scan

This study looks at how radiation therapy to the chest affects the arteries in your heart. It uses a special PET scan (with a safe radioactive tracer) to check for early signs of inflammation or plaque buildup, which can help doctors find ways to protect your heart during cancer treatment.

Los Angeles, California
NCT04262830Recruiting
Heart scans to predict future heart failure after chemotherapy

This trial uses detailed heart imaging (a special MRI scan) to see how chemotherapy may have affected your heart and to predict who could develop heart failure later. If you qualify, it may help your care team better monitor your heart health over time.

San Diego, California
NCT07838649Not yet recruiting· Phase 1
PET scans to monitor heart health during chemo

This study uses a special PET scan to see if chemotherapy can damage the heart early. The goal is to find problems sooner so doctors can protect your heart during cancer treatment.

St Louis, Missouri
NCT07419867Not yet recruiting· Phase 2
Using PET/MRI to monitor breast cancer treatment

This study tests whether a new type of PET/MRI scan can help doctors see how well breast cancer treatment is working. It is a platform study, meaning it can evaluate different treatments, but the focus is on using this advanced imaging to monitor response.

Shanghai, Shanghai Municipality

Hear when a new Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.